Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chubb
AstraZeneca
Baxter
Deloitte
Citi

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 7,666,652

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,666,652
Title:Asparaginases
Abstract: The invention relates to new asparaginases having improved properties, preferably improved thermotolerance, such as improved activity at high temperatures and/or improved thermostability. The invention also relates to DNA sequences encoding such improved asparaginases, their production in a recombinant host cell, as well as methods of using the asparaginases, in particular for reduction of acrylamide in foods. The invention furthermore relates to methods of generating and preparing asparaginase variants having improved properties.
Inventor(s): Matsui; Tomoko (Chiba, JP), Friis; Esben Peter (Herlev, DK), Yamagishi; Akihiko (Tokyo, JP)
Assignee: Novozymes A/S (Bagsvaerd, DK)
Application Number:12/044,055
Patent Claims:see list of patent claims

Details for Patent 7,666,652

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial Novozymes A/S (Bagsvaerd, DK) 2027-03-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,666,652

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2008110513 Sep 18, 2008
United States of America 2009170157 Jul 02, 2009
United States of America 2010055726 Mar 04, 2010
United States of America 2010221385 Sep 02, 2010
United States of America 7829320 Nov 09, 2010
United States of America 7871806 Jan 18, 2011
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Express Scripts
Chubb
Accenture
Cipla
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.